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Abstract  
Tissue engineering often rely on scaffolds for supporting cell differentiation and 
growth. Novel paradigms for tissue engineering include the need of active or smart 
scaffolds in order to properly regenerate specific tissues. In particular, as electrical and 
electromechanical clues are among the most relevant ones in determining tissue 
functionality in tissues such as muscle and bone, among others, electroactive materials 
and, in particular, piezoelectric ones, show strong potential for novel tissue engineering 
strategies, in particular taking also into account the existence of these phenomena within 
some specific tissues, indicating their requirement also during tissue regeneration. 
This referee reports on piezoelectric materials used for tissue engineering applications. 
The most used materials for tissue engineering strategies are reported together with the 
main achievements, challenges and future needs for research and actual therapies. This 
referee provides thus a compilation of the most relevant results and strategies and a start 
point for novel research pathways in the most relevant and challenging open questions. 
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1. Introduction 
Metals, alloys and ceramic materials are being replaced by polymers in different 
application areas including aerospace and automotive industries, electronics, sensors, 
actuators and tissue and biomedical engineering. Different processing techniques have 
been developed for the production of polymers with tailored properties, including 
electrical, mechanical, thermal, chemical and surface properties, among others, 
addressing specific applications demands [1-2]. 
Polymers present attractive properties when compared to inorganic materials. They are 
light weight, inexpensive, mechanically and electrically tough, they show excellent 
compatibility with other organic and inorganic materials for the development of 
multifunctional hybrid systems, and some of them are biodegradable and/or 
biocompatible [3-5]. 
The increasing advances in materials science and engineering is allowing the 
improvement and optimization of the so-called smart materials and, in particular, smart 
polymer materials, for a larger number of application areas [6-10].  
Smart materials are materials with reproducible, significant and stable variations of at 
least one property when subjected to external stimuli. Smart materials are typically 
classified according to the output response and include piezoelectric materials, materials 
that develop a voltage when a mechanical stress is applied or vice-versa; shape memory 
materials, in which a large deformation can be induced and recovered by temperature or 
stress variations; temperature responsive polymers, magnetostrictive materials, pH 
sensitive materials, self-healing materials, thermoelectric materials and conductive 
polymers, among others [11-13]. These materials are also generally knows as active 
materials. 
Particularly interesting for sensor and actuator applications, are materials that undergo 
deformation under a specific stimuli or than provide a specific stimuli under mechanical 
force and/or deformation. Depending on the transduction mechanism, they can be 
broadly classified as non-electrically deformable polymers (actuated by non-electric 
stimulus such as pH, light and temperature, for example) and electroactive polymers 
(EAP) when the transduction mechanism involves electro-mechanical coupling. The 
later are further classified as dielectric EAP, which electromechanical response is 
dominated by electrostatic forces and ionic EAP which actuation mechanism involves 
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the diffusion of ions [14-15]. The main types of electroactive polymers are shown in 
table 1. Electrically conductive polymers are another class of electrically active 
materials that is attracting increased attention as they show simultaneously high 
conductivity and the physico-chemical properties of polymers [16-18]. 
 
Table 1: Leading types of EAP materials (from [15]). 
Electronic EAP  Ionic EAP 
Dielectric EAP  Ionic polymer gels (IPG) 
Electrostrictive graft elastomers  Ionic polymer metal composites 
(IPMC) 
Electrostrictive paper   
Electro-viscoelestastic elastomer    Conducting polymers 
Ferroelectric polymers  Carbon nanotubes (CNT) and 
nanofibers (CNF) 
Liquid crystal elastomers (LCE)   
 
In the last decades, a variety of natural and synthetic materials with various molecular 
designs emerged as potential biomaterials for tissue and biomedical engineering [19]. 
Natural materials are attractive for biomedical and related applications as they are 
obtained from natural sources, exhibiting similar properties to the tissue they are 
replacing, many of them containing specific cues for cell adhesion and proliferation and 
allowing cell infiltration [20]. On the other hand, polymers from natural origin are often 
difficult to process and show poor mechanical and electrical properties [21]. In this way, 
a variety of synthetic polymers such as poly(lactic acid) (PLA) [22-23], poly(glycolic 
acid) (PGA) [24-25], poly(lactic-co-glycolic acid) (PLGA) [26-27], poly(ethylene 
glycol) (PEG) [28-29] and polycaprolactone (PCL) [30] have been widely used to 
produce materials/scaffolds for tissue engineering [31].  
Although an extensive list of polymer has been studied regarding tissue engineering 
applications, most of the developed scaffolds have been used in a passive way, just as 
support for the cells and tissues [32]. Nevertheless, it was verified that for some specific 
cells and tissues, the active behavior of the material used for the scaffold development 
can be taken to advantage, providing even the necessary stimuli for proper tissue 
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regeneration. This fact gave rise to the strong increase of the development of smart 
materials for tissue engineering applications [33]. 
Being electrical signals one of the main physical stimuli present in the human body and, 
in particular, the electromechanical signals, this review is devoted to summarize the 
research efforts, main conclusions, main challenges and needs as well as the strong 
potential of developing electroactive scaffolds based on piezoelectric polymers for 
specific tissue engineering applications. 
In a piezoelectric material, an electrical response due to mechanical excitation or vice 
versa can be observed. In these kind of materials a certain directionality in its structure 
was required. The synthetic polymers that are in noncrystalline or semicrystalline form 
and are originally isotropic can be subjected to a special treatment (such as corona) to 
meet this requirement [34]. By definition, the piezoelectric effect can be described by 
four piezoelectric coefficients dij, eij, gij and hij, wherein the most common used, the 
direct effect, is the dij coefficient (Equation 1). 
     (Equation 1) 
where D is the electric induction; E is the electric field strength; X is the mechanical 
stress; and  is the strain [35]. In this sense, it is possible observe that the 
piezoelectricity is the relation between the electrical variables (D and E) and the 
mechanical parameters (X and ). 
The inverse piezoelectric effect is the eij coefficient (Equation 2). 
     (Equation 2) 
The direct piezoelectric effect (dij) concerns the conversion of the mechanical energy to 
the electrical energy while the inverse piezoelectric effect (eij) is the conversion of the 
electrical energy to the mechanical energy. 
 
2. Electrical clues in human body 
Many of the major functions in cells and organs of the human body are controlled by 
electrical signals. As early as in the 18th century it is described the use of electrostatic 
charge for skin lesion treatment [36] and in 1983, electrical potentials ranging between 
10 and 60 mV depending on the human body location were measured [37]. 
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Electric fields and potentials induce distinct effects on cells and it has been proven that 
small applied electric fields can guide a variety of different cell types to move and 
migrate directionally such as corneal, epidermal and epithelial cells [38-41]; can 
modulate the phenotypes of vascular endothelial cells [42]; can regenerated nerve fibers 
[43] and are widely used in orthopedic practices, showing the improvement of ligament 
healing in vivo [44]. 
 
3.1. Piezoelectricity in human body 
Extensive and classic studies of the piezoelectric properties of bone and other biological 
materials have been also reported. The piezoelectricity can be referred as a extended 
property of living tissue, playing a significant role in several physiological phenomena 
[45]. Piezoelectricity can be thus found in different parts of the human body (figure 1) 
such as bone, tendon, ligaments, cartilage, skin, dentin, collagen, deoxyribonucleic 
acids (DNA) and conceivably, in cell membranes [45-50]. 
 
 
Figure 1 – Representative human body location in which electrical and piezoelectric 
signals are relevant. 
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Bone 
Bone is a dynamic tissue in constant adaptation and remodeling through complex 
feedback mechanisms, involving electromechanical processes, due to its piezoelectric 
characteristics. Due to its piezoelectric nature, bone is the paradigm for piezoelectric 
electromechanical effect in human tissue [51]. 
The first study reporting the piezoelectric properties of the bone was in 1955 [52]. Few 
years later, electric currents in bone and the generation of electric potentials when the 
bone is mechanically stressed were verified [53-54]. This phenomenon, recognized as 
piezoelectricity, is independent of the cell viability. The mechanical stress produces 
electrical signals and these signals represent the stimulus that promotes  bone growth 
and remodeling according to the Wolff's law [55]. The biomechanical properties of 
bone, in particular its piezoelectric activity, have been addressed microscopically [56] 
and macroscopically, with models using finite element analysis [57]. Further, it has 
been also hypothesized a mechanism by which the piezoelectric signals can regulate the 
bone growth [58]. At the cellular level, the bone cell type that plays an important role in 
the bone structure development and appears to be involved in bone 
mechanotransduction, the osteocytes, was identified [59]. Consequently, for bone 
regeneration, these cells communicate with other bone cells, such as osteoblasts and 
osteoclasts. The influence of electrical stimulation on bone healing has been studied in 
vitro [60-66] and in vivo [67-72] and it has been demonstrated that the application of 
these stimulus can enhance and stimulate osteogenic activities. In this way, the 
osteoblasts are affected by electromechanical signals to apposite bone tissue [73-74], the 
piezoelectric nature of bone, leading to natural conversion of the mechanical stimuli 
into electrical ones. 
Collagen and others piezoelectric tissues 
Due to their collagenous structure, tendons and ligaments also exhibit piezoelectricity, 
giving rise, therefore, to an electrical potential variation when a mechanical stress is 
applied [75-76]. The piezoelectricity of dry tendons was measured [77], as well as the 
electrical potentials generated in hydrated tendon [78-79], the piezoelectric coefficient 
decreasing with increasing hydration [80]. 
Piezoelectric effect has been also observed in different soft tissues, such as skin, callus, 
cartilage and tendons, as well as in hard ones, such as bone, and appears to be 
associated with the presence of oriented fibrous proteins [45, 81]. All connective tissue 
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contains one or more types of fibrous molecules such as collagen, keratin, fibrin, elastin, 
reticulum or cellulose structure, showing also piezoelectric properties [45].  
It seems evident from the literature that the piezoelectric effect can be attributed to the 
main organic constituent of tissue, which is collagen in the case of the bone and tendons 
[82-83]. Thus, it has been shown that the crystalline unit of collagen is polar hexagonal 
(C6) [56], showing piezoelectric properties. Further, as previously indicated, it has been 
shown that dry bone is piezoelectric, i.e., a mechanical stress induces a polarization 
(direct effect) and an application of an electric field produces a change in the material 
geometry or strain (converse effect). It was reported that for dry fibers, the polarization 
results from the displacement of the hydrogen bonds formed in the polypeptide chains 
of the collagen crystals. Other studies confirmed such findings. Thus, in [84] the 
piezoelectric and pyroelectric behavior of collagen were measured independently from 
the bone, confirming that the electroactive properties arise from the structure of 
collagen molecules. It was suggested that the crystalline structure of collagen changed 
under wet conditions and that the bound water promotes a change its crystal symmetry 
to the point where no piezoelectric properties were observed [78, 85]. A certain 
minimum amount of water concentration, which increases the crystal symmetry, is 
nevertheless required to maintain the overall structural integrity. Further, it was also 
suggested that, due to the variability of the electroactive behavior of collagen in wet and 
dry states, wet bone shows different piezoelectric symmetry relation [78, 85]. More 
recently, studies of the piezoelectric response of human bone using a piezoresponse 
force microscope, in order to measure this effect at nanometer scale resolution directly 
in the collagen matrix, resulted in the quantification of the piezoelectric response in 7 – 
8 pC.N-1 [86]. 
With respect to other biological tissues, the electrical polarization variations were also 
verified in hair when subjected to stress [87] as well as in DNA [75]. Finally, 
investigations in the calcifications commonly found in human pineal gland tissues 
resulted in the determination that the pineal gland contains non centrosymmetric 
material which, according to crystallographic symmetry considerations, is also 
piezoelectric [88]. 
 
3. Electrically active materials for tissue engineering  
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Advances in the understanding of electrical properties of tissues and cells are 
increasingly attracting attention to this area of research. Living cells show many 
properties of electrical systems, i.e., they generate electromotive force, regulate the 
potential difference whenever needed, use varying resistances in series or in parallel, 
switch on and off, control and rectify current flow and store charge [89-90]. An electric 
voltage exists across the plasma membrane, while the inside of the cell remains more 
negative than the outside. By convention, the potential outside the cell is called zero; 
therefore, the typical value of the membrane potential is in the range of -60 to -100 mV 
[91]. 
Thus, conductive polymers have been applied in tissue engineering applications. One of 
the most studied conductive polymers for tissue and biomedical engineering is 
polypyrrole (PPy) that has been proven to be a promising substrate for cell growth and 
proliferation, in particular for axon growth in vitro and in vivo experiments [90, 92]. 
Studies reveal that the application of an external electrical stimulus to the material, and 
consequently to the cell, enhances axons outgrowth to levels beyond the ones obtained 
for cultures on non-conducting polymers [92-93]. One of the major drawbacks of the 
used conductive polymers for in vivo applications is their inherent inability to 
biodegradation, which may induce chronic inflammation and require surgical removal 
[94]. In order to solve this issue, attempts to blend them with suitable biodegradable 
polymers have been carried out. Thus, nerve guidance channels (NGCs) were fabricated 
from an electrically conductive, biodegradable polymer of PPy and poly(D,L-lactide-co-
epsilon-caprolactone) (PDLLA/CL) [92]. Further, the influence of the applied current 
intensity in the neurite outgrowth was evaluated and it was found that a current intensity 
of 1.7–8.4 µA/cm leads to the largest enhancement of neurite outgrowth on conductive 
PDLLA/CL and PPy surfaces.  
Polyaniline (PANI) is the oxidative product of aniline under acidic conditions and is 
commonly known as aniline black [95] and the ability of PANI and PANI variants to 
support cell growth has been evidenced [96], independently of the oxidation state [97]. 
In this way, adhesion and proliferation of cardiac myoblasts (H9c2) on conductive 
PANI substrates have been reported [98]. Both non-conductive emeraldine base and 
conductive salts forms of PANI were found to be biocompatible and to support cell 
attachment and proliferation, which attracted much attention of this material for tissue 
and biomedical applications. Further, there are other electrically conductive polymers 
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that are being studied for tissue and biomedical engineering such as poly(3, 4-
ethylenedioxythiophene) (PEDOT) for cochlear implants, vision prosthesis, neural 
regeneration devices and neural recording electrodes [99]. 
Carbon nanotubes (CNTs) are other group of conducting fi llers incorporated into non-
conductive polymers to provide structural reinforcement and electrical conductivity into 
the scaffolds and to direct cell growth [100]. Some studies indicated that CNTs are 
cytotoxic, while others revealed that carbon nanotubes are excellent substrates for 
cellular growth [100]. As a result of these studies, it is claimed that when used in 
suspension, CNTs seems to be toxic to cells, while they appear to be non-toxic if 
immobilized into a specific polymer matrix or culture dish [101]. 
Table 2 summarizes some relevant experimental conditions and cells used for electrical 
stimulation based on electrically conductive polymers. These materials have been 
particularly explored for neural development and it was verified that the application of 
electric fields influence the rate and orientation [43] and also the extension and direction 
[102] of the neurite outgrowth of cultured neurons in vitro.  
 
Table 2: Relevant works on electrical stimulation conditions applied in tissue 
engineering strategies based on conductive polymers (adapted from [90]).  
Conductive Scaffolds 
dc/ac current; 
potential 
Duration Cells 
PANI/PCL/gelatin dc: 100 mV 1 h 
Mouse neuronal 
cerebellum stem 
cells (C17.2) 
PANI/poly(L-lactide-co-ε-
caprolactone) 
(PANI/PLACL) 
dc: 0 - 200 mA 48 h NIH-3T3 fibroblasts 
PPy dc: 100 mV 2 h 
Rat neuronal 
phaeochromocytoma 
(PC12) 
PLGA coated with PPy 10 mV cm-1 2 h PC12 
PPy/poly(L-lactic acid) 
(PPy/PLLA) 
dc: 100 mV mm-1 2, 24 h 
Human skin 
fibroblasts 
PDLLA/CL coated with 
PPy 
dc: 0, 2, 8 e 20 µ
A mm-1 mV-1 
- PC12 
PPy ac: 50 µA at 0,05, - Vascular smooth 
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5 and 500 Hz muscle cells 
(VSMC) 
PPy/PLLA dc: 50 mV mm-1 24h 
Human cutaneous 
fibroblasts 
Indium–tin oxide (ITO) 
ac: 100 mV (100 
Hz) 
30 min/day 
(3 days) 
PC12 
PLLA/CNT 
ac: 10 mA (10 
Hz) 
6 h/day Osteoblasts 
PCL/PPy dc: 10 V 4 h/day 
Dorsal root ganglia 
(DRG) 
PPy 
Biphasic 100 µs 
pulses of 1 
mA.cm-2 at 250 
Hz 
8 h/day 
Cochlear neural 
explants 
copolymer of 
hydroxyl-capped PLA and 
carboxyl-capped aniline 
pentamer (AP) (PLAAP) 
Electric potential 
of 0.1 V (1 Hz) 
1 h/day PC12 
PPy/Chitosan dc: 100 mV 4 h Schwann Cells 
 
Common to the aforementioned materials is the need of an external power supply in 
order to induce electrical signals and thus to promote electrical stimulus to the cells. 
This is a strong drawback for in-vivo applications and thus, it is important to develop a 
generation of biomaterials including combinations of biological, chemical, mechanical 
and electrical stimulatory cues, being the last ones without external power supply and 
therefore wires. 
In this scope, piezoelectric polymers appear as a possibility for applying electrical 
signals to the cells by mechanoelectrical transduction. Piezoelectric materials generate 
transient surface charge variations and therefore electrical potential variations when 
mechanical solicitation are applied to the material and, therefore, no need for additional 
energy sources or electrodes [103] are requires.  
 
4. Piezoelectric soft biomaterials and structures 
General for all materials used as scaffolds, the design of these bioactive biomaterials is 
another important parameter to consider and a suitable morphology, in combination to 
the piezoelectric characteristics, has to be optimized proper cell response.  
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Many processing methods have been developed to process biomaterials into scaffolds 
with different dimensionalities and morphologies [104-105]. Different structures of 
biomaterials including microspheres, fibers, porous membranes, hydrogels and sponges 
have been designed and used in tissue engineering [19]. However, effects of internal 
biomaterials structures remain largely unexplored and the comparison of cell response 
in the different structures types remains elusive. In particular, just a few scaffold 
morphologies have been used for piezoelectric tissue engineering including films, 
membranes and fibers, among others. Some structures of -poly(vinylidene fluoride) 
(PVDF) are shown in Figure 2.  
 
 
Figure 2 – -PVDF obtained in different morphologies: a) porous membranes, b) 
electrospun fibers and c) microparticles. 
 
Porous scaffolds have been obtained by solvent casting/salt leaching, phase separation, 
gas foaming, gel casting, precipitation and emulsion freeze-drying [104-105]. The main 
drawbacks of these methods are associated with the possibility to obtain scaffolds with 
an inaccurate and limited interconnectivity pore morphology that is disadvantageous for 
uniform cell seeding and tissue growth [31, 106]. This major drawbacks can be 
overcome by fibrous scaffolds produced by electrospinning, a method that offers the 
ability of control the pore interconnectivity and moreover the internal and external 
morphology of fibers by controlling processing parameters such as applied voltage, 
solution viscosity and conductivity, among others [106]. Moreover, electrospinning 
allows the production of scaffolds with small pore size, density and high surface area 
[105-106]. The pores of the scaffolds should be large enough to allow cell migration, 
where they eventually become bound to the ligands within the scaffold. Therefore, for 
any scaffold, a critical range of pore sizes exists, which may vary depending on the cell 
type and tissue being engineered [107]. The fiber diameter of the scaffolds produced by 
electrospinning can range from 5 to 1000 nm [106]. A similar method to electrospinning 
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is electrospray, which allows the preparation of polymeric micro- and nanoparticles that 
can also be used as support for cell expansion and differentiation [108-109]. Other 
methods can be used for particle formation however this method might overcome some 
of the drawbacks associated with conventional microparticle-producing methods, such 
as solvent casting, single and double emulsion, spray-drying, porous glass membrane 
emulsification and coacervation [108]. 
More recently, rapid prototyping (RP) technologies also known as solid free-form 
fabrication (SFF) allows translating computer data files such as computer-aided design 
(CAD), computed tomography (CT), magnetic resonance imaging (MRI) and convert 
the digital information through layered manufacturing SFF machines into a 3D scaffold 
[105-106, 110]. Three-dimensional printing (3DP), fused deposition modeling (FDM), 
stereolithography apparatus (SLA) and selective laser sintering (SLS) are widely been 
applied in the fabrication of materials with unique geometries with controllable pore 
architecture which could not obtained by conventional methods [106, 108]. Various 
biomaterials are commonly used in RP technologies such as PEG, PLGA, PCL, 
collagen, starch, HA and TCP [104, 111-112]. However, to the best of our knowledge 
few studies report the production of piezoelectric scaffolds by these methods. It is 
known that stereolithography is the most commonly method used for fabricate 
piezoelectric scaffolds based on PLLA [112]. 
 
These scaffold structures have to be achieved with the few natural and synthetic 
materials exhibiting piezoelectric properties, the most relevant ones, with the respective 
piezoelectric properties being reported in table 3 and 4, respectively.  
 
Table 3 – Biodegradable polymers with natural origin and corresponding main 
piezoelectric response (adapted from [75]). 
Natural Polymers 
Piezoelectric 
coefficient  
-d14 (pC/N) 
Polysaccharides 
Cellulose 
wood 0.10 
ramie 0.20 
Chitin crab shell 0.20 
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lobster apodeme 1.50 
Amylose starch 2.00 
Proteins 
Collagen 
bone 0.20 
tendon 2.00 
skin 0.20 
Keratin 
wool 0.10 
horn 1.80 
Fibrin 
elongated films of fi
brinogen-thrombin clot 
0.20 
Deoxyribonucleic acids 
salmon DNA (at -100 ºC) 
0.07 
 
However, to take advantage of the piezoelectric properties, synthetic polymers have 
been chosen instead the natural ones for their use as tissue engineering scaffolds. These 
have known compositions and can be designed to minimize immune response. They can 
be tailored to produce a wide range of scaffold geometries and hybrid structures by 
combining polymers with other organic or inorganic hybrid structures. 
Among all polymers, PVDF [113] and vinylidene fluoride (VDF) [114] copolymers, are 
the synthetic, semi-crystalline polymers with the highest electroactive properties, 
including piezoelectric, pyroelectric and ferroelectric properties [114]. 
 
Table 4 – Piezoelectric natural and synthetic polymers. 
Polymer  
Dielectric constant 
(1 kHz; 25ºC) 
Piezoelectric 
Coefficient (pC/N) 
Ref. 
PLA 
3.0 – 4.0 9.82 
[115-
116] 
Polyhydroxybutyrate (PHB) 
2.0 – 3.5 1.6 – 2.0 
[117-
118] 
PVDF 
6 - 12 24 - 34 
[119-
120] 
Poly(vinylidene fluoride-
trifluoroethylene) (PVDF-
18 38 [120] 
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TrFE) 
Polyamide-11 5 4 [121] 
 
As previously mentioned, it is possible to find electrical activity and even 
piezoelectricity in many parts of the human body. For that reason, it seems be 
advantageous to employ biomaterials based on piezoelectric properties for active tissue 
engineering of specific tissues. 
 
5. Tissue engineer ing based on piezoelectr ic polymers 
Studies of the use of piezoelectric polymers for tissue engineering applications are 
mostly devoted to bone, neural and muscle regeneration.  
Table 5 summarizes the main works using piezoelectric polymers, the intended 
applications and scaffold morphology, together with the cultivated cells. 
 
15 
 
Table 5 – Material type, scaffold design and cells used for different applications. 
Applications Mater ial type Scaffold design Cells type used Ref. 
Bone 
regeneration 
or   
Bone tissue 
engineer ing 
PVDF and copolymer  
Films 
MC3T3-E1 
Goat marrow stromal cells into 
osteoblast 
[122-
124] 
[125]* 
Fibers 
Human mesenchymal stem cells 
(MSCs) 
[126] 
Blends membranes (porous) NIH3T3 mouse fibroblast [127] 
PLLA 
Films Implementation on male cats [128] 
Fibers 
Human fetal osteoblasts (hFOB) 
Human mandible–derived 
mesenchymal stem cells (hMSCs) 
[129] 
[130] 
PHB and copolymers  
Films Bone marrow cells [131] 
Fibers 
Human osteoblasts (HOB)  
Bone marrow cells 
[132] 
[131] 
3D Blends membranes 
(porous) 
MC3T3-E1 [133] 
 
Collagen 
Fibers - hydrogel D-periodic 
type I collagen fibrils 
Rat tail tendon  [134] 
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3D matrices 
Human fetal osteoblastic cells 
(hFOB 1.19) and Bovine 
osteoblasts 
Human adipose-derived stem cells 
(ASCs) 
[135] 
 
[136] 
Composites 
PVDF/starch/natural 
rubber (NR) 
Blends membranes (porous) NIH3T3 mouse fibroblast [127] 
PVDF-
TrFE/starch/NR 
Blends membranes (porous) NIH3T3 mouse fibroblast [127] 
PVDF-TrFE/Barium 
titanate (BT) 
Membranes 
in vivo evaluation of rats 
Human alveolar bone-derived cells 
(Osteoblastic cells) 
Osteoblastic cells from human 
alveolar bone fragments 
Fibroblasts from human periodontal 
ligament (hPDLF) and 
keratinocytes (SCC9) 
[137] 
[138] 
 
[139] 
 
[140] 
PLA/demineralized 
bone powders (DBP) 
Fibers hMSCs [130] 
PLLA covered with 3D Porous Scaffold Saos-2 osteoblast-like cells [141] 
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bonelike apatite  
Apatite/collagen  3D Porous Scaffold Saos-2 osteoblast-like cells [141] 
Nerve or  
neural 
regeneration 
PVDF 
Films 
Mouse neuroblastoma cells (Nb2a) 
Spinal cord neurons 
[43, 
142]* 
[143] 
Blends membranes (porous) 
Dense and microporous 
membranes: neuronal cells 
[144] 
Channels/Tubes 
Nerve guidance channels: in vivo 
assay: mouse sciatic nerve model. 
Tube containing nerve growth 
factor (NGF) and Collagen gel: in 
vivo assay: Wistar rats. 
[145] 
 
[146] 
PVDF-TrFE 
Films 
Poietics Normal Human Neural 
Progenitors 
Nb2a 
[147] 
 
[43] 
Fibers 
Dorsal root ganglion  
Poietics normal human neural 
progenitors 
[148] 
[147] 
Tubes In vivo implementation: rat sciatic [149] 
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nerves 
PLLA 3D Porous scaffold 
In vivo implementation: Sprague 
Dawley rats 
[150] 
Collagen 
Fibers Schwann cells [151] 
3D gel matrices Embryonic rat cerebral cortices [152] 
Muscle 
regeneration 
PVDF 
Films C2C12 myoblast [153] 
Fibers C2C12 myoblast [153] 
Meshes In vivo study in rabbits [154] 
Fibers In vivo study in rabbits [155] 
Composites Au–PLLA Fibers primary rat muscle cells [156] 
Others 
applications 
Cartilage PHB 3D scaffolds 
Human adipose-derived stem cells 
(hASCs) 
[157] 
Abdominal hernia 
repair 
PVDF Meshes Implanted subcutaneously in rats 
[158] 
[159] 
Endothelialization PVDF Films Human cell line, EA.hy 926 [42] 
Vascular surgery PVDF Monofilament sutures 
In vivo study 
Adult female chinchilla rabbits 
[160] 
[161] 
Spinal cord injury 
regeneration 
PHB-co-3-
hydroxyvalerate 
3D scaffold by freeze-
drying technique 
primary culture of neurons and 
astrocytes from the hippocampus of 
[162] 
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(PHB-HV) P4 Wistar rats 
Wound healing 
PPy/PLLA  Membranes Human Skin Fibroblast  [163] 
PVDF-TrFE Electrospun fibers Human skin fibroblasts [164] 
Tissue sensors PVDF Microstructures Human osteosarcoma (HOS)  [165] 
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Dynamic assays were performed in the studies marked with * contrary to the others 
where only static assays were carried out. It is to notice that when no dynamic 
conditions are used, the suitability of the piezoelectric effect is not proven, but just the 
suitability of the material. 
It is to notice that the most used polymer is PVDF and co-polymers as, due to its larger 
piezoelectric response, serve as an ideal material platform for proving the concept of 
mechano-electrical transductions for tissue engineering. Also several sample 
morphologies have been used, such as films, fibers, porous membranes and 3D porous 
scaffolds for different applications in tissue engineering, mainly for bone, muscle and 
nerve regeneration. With the challenge to mimic the architecture of these tissues, the 
fibers have proved to be one of the favorite choices and for most of the studies 
mesenchymal stem cells have been chosen. For bone tissue engineering applications, 
PVDF fibers were produced and its effect on biological function was studied with 
hMSCs [126]. It was verified that the cells attach to the PVDF fibers and present a 
greatest alkaline phosphatase activity and early mineralization when compared with the 
control, showing the potential for the use of PVDF scaffolds for bone tissue engineering 
applications. The same cells was also used with PLLA fibers to study their 
biocompatibility and suitability for bone differentiation and the same results was 
obtained [130]. Regarding nerve regeneration, fibers was also used and it was verified 
that the cells attach and the neurites extend radially on the random aligned fibers, 
whereas the aligned fibers directed the neurite outgrowth, demonstrating their potential 
for neural tissue engineering [147-148]. 
On the other hand, despite the demonstrated potential, there is still just a few conclusive 
works addressing the effect of the electrical stimulus promoted by the piezoelectric 
response of the materials, as for these studies, specific dynamical mechanical stimulus 
should be applied during cell culture. 
In this scope, piezoelectric materials based on PVDF films, have been used to study the 
effect of mechanical stimulation of bone cells, by converse piezoelectric effect. On a 
substrates submitted to dynamic mechanical conditions, the stimulation was achieved 
with an alternating sinusoidal current (AC) of 5 V at 1 and 3 Hz for 15 min at each 
frequency. It was verified that mechanical stimulation of bone induces new bone 
formation in vivo and increases the metabolic activity and gene expression of 
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osteoblasts in culture [105-106]. The influence of the same piezoelectric substrate, 
PVDF film, on the bone response cultivated under static and dynamic conditions was 
also investigated [107]. The dynamic culture was performed on a home-made bioreactor 
system with mechanical stimulation by placing the culture plate on a vertical vibration 
module at a frequency of 1 Hz with amplitude of ~1 mm. The results showed that the 
surface charge under mechanical stimulation improves the osteoblast growth and 
consequently, that electroactive membranes and scaffolds can provide the necessary 
electrical stimuli for the growth and proliferation of electrically responsive tissue and in 
particular of tissues which also show piezoelectric response, such as bone. The same 
dynamic culture was used to enhanced osteogenic differentiation of human adipose stem 
cells, proving that dynamic mechanical stimulus in combination with suitable 
osteogenic differentiation media can offer tools to better mimick the conditions found in 
vivo [108]. 
Concerning nerve regeneration, neurons were cultured directly on electrically charged 
PVDF polymer growth substrates to determine if local electrical charges enhance nerve 
fibre outgrowth in vitro [86]. Piezoelectric PVDF substrates generated 2-3 mV at 1200 
Hz when placed on standard incubator shelves and it was conclude that the enhanced 
outgrowth process was induced effectively by the piezoelectric output of the films. 
 
22 
 
6. Final remar ks, conclusions and main challenges 
The tissue engineering has emerged as an alternative to conventional methods for tissue 
repair and regeneration, but different strategies can be chosen; as represented in Figure 
3. Basically, it consists in choosing appropriate cells, materials and biochemical and 
physical signals to repair, maintain or regenerate the tissue function. The cells can be 
harvested directly from the patient or stem cells can be used to be combine with an 
biomaterial scaffold to grown in vitro without (route B of figure 3) or with (route C of 
figure 3) signals and then implanted. It should be also noted that the bioreactor use in 
tissue engineering is an attempt to simulate an in vivo physiological environment. The 
scaffold can also be implanted directly to facilitate the cell regeneration in vivo (route A 
of figure 3). 
 
 
Figure 3 – Schematic representation of the different strategies of the tissue engineering 
field: 1 - The cells can be harvested directly of the patient; A - Scaffold implanted 
directly; B - Cells cultured in scaffold and then implanted; C - Cells cultured in scaffold 
with appropriate signal, namely chemical (such as growth factors) and physical (such as 
mechanical using a bioreactor) and then implanted. 
Within this general strategy, it seem evident the need of physical and biochemical 
stimuli giving rise to the suitable environment for tissue regeneration. In particular, it is 
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proven that one of the most interesting effects to be applied in a next generation of 
materials is the possibility of electrical stimulation required and promote electrical 
stimulus to the cells, which is essential to improve functionality of the regenerated 
tissue.  
A biomimetic approach also show the need of piezoelectric scaffolds and supports for 
tissue engineering applications, related to the existence of this phenomena in the living 
tissue.  
In particular, bone, as the paradigm of piezoelectric tissue, can undergo increased 
regeneration success rate by applying piezoelectric related tissue engineering strategies. 
Thus, Figure 4 shows a promising strategy for the repair or regeneration of damaged 
bone. This tissue engineering therapy involves harvesting healthy cells (adult or stem 
cells) culturing in an appropriate scaffold for the grown in vitro in a bioreactor which 
will provide the proper biochemical and physical stimulus and then implanted. The 
main purpose of this strategy is recreating the bone tissue environment such as the 
biochemical and mechanical stimulus.  
 
 
Figure 4 – Tissue engineering strategies for bone regeneration.  
It can be concluded that piezoelectric materials can be used for further explore and 
implement tissue engineering strategies, as the materials, with suitable piezoelectric 
response can be tailored in terms of material properties and microstructure, as well as 
suitable scaffolds designs can be prepared. On the other hand, their fully potentials has 
not been achieved and suitable bioreactors should be developed mimicking in-vivo 
conditions and exploring the mechanical stimulation of the materials to get suitable 
electrical response. 
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A new generation of studies involving bioreactors is needed before in-vivo testing in 
order to achieve a deep knowledge of the mechanoelectro transduction effects on the 
specific cells.  
One this is achieved, two strategies can be followed based on piezoelectric stimulation 
(figure 3 and 4): 
a) Bioreactor culture for pre-differentiation and cell implantation 
b) Scaffold implantation 
For the later a new generation of piezoelectric materials with controlled biodegradation 
will be needed. 
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